Chronic Selective Endothelin A Receptor Antagonism Reduces Serum Uric Acid in Hypertensive Chronic Kidney Disease

被引：11
|
作者：
Dhaun, Neeraj [1 ,2 ]
Johnston, Neil R. [1 ]
Goddard, Jane [2 ]
Webb, David J. [1 ]
机构：
[1] Univ Edinburgh, Clin Pharmacol Unit, British Heart Fdn, Ctr Res Excellence,Queens Med Res Inst, Edinburgh, Midlothian, Scotland
[2] Royal Infirm Edinburgh NHS Trust, Dept Renal Med, Edinburgh, Midlothian, Scotland
来源：
HYPERTENSION | 2011年 / 58卷 / 02期
关键词：
CARDIOVASCULAR RISK; BLOOD-PRESSURE; HYPERURICEMIA; ALLOPURINOL; PROGRESSION; MORTALITY; COHORT; LEVEL;
D O I：
10.1161/HYPERTENSIONAHA.111.175646
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E11 / E12
页数：2
相关论文
共 50 条
  • [1] Selective endothelin A receptor antagonism in patients with proteinuric chronic kidney disease
    Provenzano, Michele
    Andreucci, Michele
    Garofalo, Carlo
    Minutolo, Roberto
    Serra, Raffaele
    De Nicola, Luca
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (03) : 253 - 262
  • [2] Selective endothelin A receptor antagonism in chronic kidney disease: improving clinical application
    Moedt, Erik
    Wasehuus, Victor S.
    Heerspink, Hiddo J. L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025, 40 : i37 - i46
  • [3] Chronic Endothelin - A Receptor Antagonism Reduces Proteinuria, Blood Pressure and Arterial Stiffness in Chronic Kidney Disease
    Dhaun, N.
    MacIntyre, I. M.
    Kerr, D.
    Melville, V.
    Johnston, N. R.
    Goddard, J.
    Webb, D. J.
    SCOTTISH MEDICAL JOURNAL, 2010, 55 (01) : 47 - 47
  • [4] CHRONIC ENDOTHELIN-A RECEPTOR ANTAGONISM REDUCES PROTEINURIA, BLOOD PRESSURE & ARTERIAL STIFFNESS IN CHRONIC KIDNEY DISEASE
    Webb, D. J.
    Dhaun, N.
    MacIntyre, I. M.
    Kerr, D.
    Melville, V
    Johnston, N. R.
    Goddard, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 : 27 - 27
  • [5] Selective Endothelin-A Receptor Antagonism Reduces Proteinuria, Blood Pressure, and Arterial Stiffness in Chronic Proteinuric Kidney Disease
    Dhaun, Neeraj
    MacIntyre, Iain M.
    Kerr, Debbie
    Melville, Vanessa
    Johnston, Neil R.
    Haughie, Scott
    Goddard, Jane
    Webb, David J.
    HYPERTENSION, 2011, 57 (04) : 772 - +
  • [6] Endothelin-A receptor antagonism offers hypertensive patients with chronic kidney disease cardiovascular and renal protection
    Webb, D.
    Dhaun, N.
    Melville, V.
    Lilitkarntakul, P.
    Goddard, J.
    JOURNAL OF HYPERTENSION, 2008, 26 : S202 - S202
  • [7] Combined Association of Serum Uric Acid and Metabolic Syndrome with Chronic Kidney Disease in Hypertensive Patients
    Dai, Haijiang
    Lu, Shijuan
    Tang, Xiaohong
    Lu, Minggen
    Chen, Ruifang
    Chen, Zhiheng
    Yang, Pingting
    Liu, Chang
    Zhou, Honghao
    Lu, Yao
    Yuan, Hong
    KIDNEY & BLOOD PRESSURE RESEARCH, 2016, 41 (04): : 413 - 423
  • [8] Elevated Serum Uric Acid Predicts Chronic Kidney Disease
    Yamada, Tamaki
    Fukatsu, Mitsuru
    Suzuki, Sadao
    Wada, Tsuneya
    Joh, Takashi
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2011, 342 (06): : 461 - 466
  • [9] Serum Uric Acid and Chronic Kidney Disease: The Role of Hypertension
    Sedaghat, Sanaz
    Hoorn, Ewout J.
    van Rooij, Frank J. A.
    Hofman, Albert
    Franco, Oscar H.
    Witteman, Jacqueline C. M.
    Dehghan, Abbas
    PLOS ONE, 2013, 8 (11):
  • [10] Association of uric acid and uric acid to creatinine ratio with chronic kidney disease in hypertensive patients
    Nathalia Rabello Silva
    Camila Evangelista Torres Gonçalves
    Danilo Lemes Naves Gonçalves
    Rosângela Minardi Mitre Cotta
    Luciana Saraiva da Silva
    BMC Nephrology, 22
12345